Designing CD8+ T cell vaccines: it's not rocket science (yet).
about
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 MiceEnhancement of MHC-I antigen presentation via architectural control of pH-responsive, endosomolytic polymer nanoparticles.pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challengesDesigning vaccines based on biology of human dendritic cell subsetsVaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria modelImpaired memory CD8 T cell responses against an immunodominant retroviral cryptic epitopeInduction and function of virus-specific CD4+ T cell responses.Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.From optical bench to cageside: intravital microscopy on the long road to rational vaccine design.Cross-presenting CD103+ dendritic cells are protected from influenza virus infection.In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity.Just-in-time vaccines: Biomineralized calcium phosphate core-immunogen shell nanoparticles induce long-lasting CD8(+) T cell responses in mice.Melanoma vaccines: developments over the past 10 years.A comparison of immunotherapy delivery methods for allergen immunotherapy.Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.Allergen immunotherapy in allergic rhinitis: current use and future trends.The Human Vaccines Project: A roadmap for cancer vaccine development.Gold nanocluster-based vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.Human Lung Mononuclear Phagocytes in Health and Disease.Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants.Is The Allergen Really Needed in Allergy Immunotherapy?Immunology: Cross-dressers turn on T cells.Dead Tumor Cells Expressing Infectious Salmon Anemia Virus Fusogenic Protein Favor Antigen Cross-Priming In Vitro.Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination.Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.Peptide mimic for influenza vaccination using nonnatural combinatorial chemistry.CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells
P2860
Q30392456-F58B22A3-6722-4F2D-8B27-292C5A616AD9Q30877907-7AAF1C80-A42B-46CF-BF89-3F26FAD87108Q33703757-4DADBB15-156E-40CC-9941-4D91CBC206ECQ33916635-A292C4E8-455C-4368-9769-1FE186EAB228Q34289152-7EA4D148-DAED-4A79-889B-4B3629D6EE9FQ34398787-750162B6-DAD3-4570-BA62-D0A1DBBE24D5Q34699353-F9140886-AE01-4538-9DFA-459FF628DBE3Q34856857-61F23A8E-4D0B-4AAD-B132-824F17D833C6Q35518723-A6B266C2-EE8E-4DA7-8A36-9155F957DBBCQ36108239-867EF8C9-AA93-4223-8A2B-306E9CEF8D05Q36357778-84F5F5A2-DD6B-4569-ADB5-88AC2623F84EQ36841431-9E9B655E-176E-4214-8090-1B6C66BC60E6Q37666019-F51763EB-7129-4C1F-9FAB-D67382ED96FDQ37892595-82FF39EC-5AF1-427C-8C09-4954FF362268Q38103286-007A33A3-7F8F-4201-9907-E79DC30DD178Q38217708-1381BC21-3ECE-410C-AD0D-28F1225D6F2DQ38680655-A604DFC0-85CB-4E5B-A8D5-04AD08B7B0CAQ38807692-7226D695-6E0E-42F6-8FB0-C95E83B0DB4BQ38858337-5E8D0888-873C-4CF8-95BD-42931A97FA96Q39308555-7C69061E-C9C9-4116-987C-1B61638667D4Q40139850-071AC916-09EC-411C-A9F2-78A43A5BE65DQ42378276-903B959C-8141-4148-9033-F1452BE9E324Q42730811-67272613-87A3-470F-B684-14503932FE90Q43227647-02799C78-1499-4565-B514-B729C73A8F76Q45325823-54D721D3-9E51-41B9-9BB7-9D3D7C07C440Q49013708-1180DA66-BF0D-4A16-8059-CAD6E581E7CBQ52714411-DF09DD97-20A3-4E85-B1A7-E1DF9AED469FQ52727193-96223C94-696F-4841-BBCC-36F0FA07A409Q58800691-4214B51F-C85D-4519-8DC4-47F85DE1CD17
P2860
Designing CD8+ T cell vaccines: it's not rocket science (yet).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Designing CD8+ T cell vaccines: it's not rocket science (yet).
@en
Designing CD8+ T cell vaccines: it's not rocket science
@nl
type
label
Designing CD8+ T cell vaccines: it's not rocket science (yet).
@en
Designing CD8+ T cell vaccines: it's not rocket science
@nl
prefLabel
Designing CD8+ T cell vaccines: it's not rocket science (yet).
@en
Designing CD8+ T cell vaccines: it's not rocket science
@nl
P2860
P1476
Designing CD8+ T cell vaccines: it's not rocket science (yet).
@en
P2860
P304
P356
10.1016/J.COI.2010.04.002
P577
2010-05-04T00:00:00Z